Shares of T2 Biosystems (NASDAQ:TTOO) stock are rising higher after the medical diagnostics company disclosed that the Nasdaq Hearings Panel had provided it with an extension to regain compliance.

Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today ...

Research analysts at StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO – Get Free Report) in a report released on Monday. The brokerage set a “sell” rating on the medical equipment ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

T2 Biosystems (NASDAQ:TTOO) Inc. shares have tumbled to a 52 ... This significant downturn reflects a staggering 1-year change, with the stock value eroding by nearly 95%. According to ...

Real time quote data is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of ...